SB590885是B-Raf的抑制剂,Ki为0.16 nM,对其它人类激酶无活性。
SB590885 is a potent and selective inhibitor of B-Raf kinase with Ki value of 0.16nM. SB590885 has shown selectivity for Raf-B against 46 other kinases. SB 590885 has been shown to decreases anchorage-independent growth of melanoma cell lines and also known to inhibit phosphorylation and proliferation.
2% Cremophor EL, 2% N,N-dimethylacetamide, pH 5.0
~10 μM
50 mg/kg/day 腹腔注射
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] King AJ, et al. Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885. Cancer Res, 2006, 66(23), 11100-11105.
[2] Takle AK, et al. The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. Bioorg Med Chem Lett, 2006, 16(2), 378-381.
[3] Smalley KS, et al. Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas. Mol Cancer Ther, 2008, 7(9), 2876-2883.
分子式 C27H27N5O2 |
分子量 453.54 |
CAS号 405554-55-4 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 10 mM |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们